On this page
What is Breast Fibroadenoma?
A breast fibroadenoma is the most common benign solid tumor of the breast. It primarily affects women, especially during their younger years, and while its name may sound alarming, it is important to understand from the outset that fibroadenomas are non-cancerous growths.
Fibroadenomas typically appear as rounded, nodular formations, often described as resembling a small hazelnut in shape, with a smooth, well-defined surface. The exact causes remain unknown, but several risk factors seem to play a role:
- Family history of breast conditions
- Genetic predisposition
- Hormonal imbalances between estrogens and progesterone
Clinically, a fibroadenoma presents as a breast lump with the following key characteristics:
- Round or oval shape
- Small size (usually less than 2 cm in diameter)
- Painless to the touch
- Smooth surface with regular, well-defined borders
- Mobile: it moves easily under the skin and against surrounding tissue
- Soft to firm rubbery consistency
Diagnosis typically involves a thorough medical history and physical examination, supported by imaging studies such as mammography or breast ultrasound. If the lesion appears suspicious, a cytological or histological examination through fine-needle aspiration (FNA) or core needle biopsy may be recommended.
In most cases, a fibroadenoma does not require any treatment. However, its progression should be monitored over time with regular check-ups. In certain circumstances, such as suspected malignancy or significant growth in size, surgical removal may be indicated.
Causes and Classification
Who Is Affected?
Fibroadenomas tend to develop in young women, typically from the age of 15 onwards, with peak incidence between the ages of 20 and 40. Their prevalence decreases with age, reaching a minimum during the post-menopausal period.
What Causes a Fibroadenoma?
The precise causes of fibroadenoma formation remain unknown. However, the prevailing hypothesis points to a strong correlation with hormonal levels, particularly estrogen. This is supported by the fact that fibroadenomas often shrink or disappear after menopause, when estrogen levels naturally decline.
Key risk factors that may contribute to fibroadenoma development include:
- Genetic predisposition
- Family history: The risk is increased if a close relative has had a fibroadenoma or other breast tumors
- Elevated estrogen levels: Young women typically have higher estrogen levels, which may explain why fibroadenomas are more common in this age group and less prevalent after menopause
Types of Fibroadenoma
Fibroadenomas can be classified into two main forms:
-
Simple Fibroadenoma: Presents as a benign mass that grows very slowly, sometimes stopping entirely and remaining stable in size throughout a person’s life. This is the most common type and carries no significant risk of malignant transformation.
-
Complex Fibroadenoma: Shows consistent growth over time and is associated with a slightly increased risk of malignant transformation. Histologically, this form has a more complex structure, often containing:
- Fluid-filled cystic areas
- Areas of microcalcification (calcium salt deposits)
The complex form is associated with larger lesions and requires short-interval periodic follow-up.
Additional Classifications
- Multiple Fibroadenomas: In predisposed women, multiple fibroadenomas may develop in one or both breasts, sometimes associated with fibrocystic breast disease.
- Giant Fibroadenomas: When lesions exceed 5 cm in diameter, they are classified as “giant fibroadenomas” and typically require more active management.
Symptoms
A fibroadenoma typically presents as a palpable lump in one or both breasts. The texture of the nodule can vary:
- Soft
- Firm and rubbery
- More rigid (particularly when diffuse calcifications are present)
The surface is smooth, and the borders are well-defined and regular, features characteristic of benign tumors. A key distinguishing feature is the absence of pain, except in advanced cases where the fibroadenoma has grown considerably.
- Average size: 1–2 cm, but can grow up to 6–7 cm
- Typical texture: Moves freely and easily under the skin when touched (sometimes called a “breast mouse” due to its mobility)
How Fibroadenoma Size Can Change
In specific situations, a fibroadenoma may change in size relatively quickly:
- During pregnancy: Hormonal changes can trigger significant and rapid growth over a matter of weeks
- After menopause: The lesion may regress and shrink to the point of no longer being palpable, due to reduced estrogen stimulation
Diagnosis
Medical History (Anamnesis)
The diagnostic process begins with a comprehensive medical history, in which the physician asks the patient a series of targeted questions to reconstruct their clinical background. Key information includes:
- Age at which the fibroadenoma first appeared
- Family history of fibroadenoma or other breast conditions
- Any changes in the characteristics of the lump
- Presence of underlying medical conditions
- Pregnancy or menopausal status
- Age at first menstruation (menarche) and regularity of the menstrual cycle
Physical Examination
A thorough physical examination is essential in evaluating breast pathology. The examination should extend beyond the breasts to include the armpits (axillae), supraclavicular spaces, and neck, to detect any enlarged lymph nodes.
Inspection is performed with the patient seated, evaluating:
- Breast symmetry, size, and shape
- Any nipple discharge
- Signs of inflammation, such as redness, swelling, or pain (suggestive of mastitis)
Palpation is carried out both seated and lying down. The physician uses the palm of the hand and fingertips to systematically examine both breasts, including the areola, nipple, and axillary tail of each gland.
Warning Signs of a Suspicious Breast Lump
The following findings should prompt urgent medical evaluation:
- Changes in breast shape or size
- Thickening or nodularity in the axillary area
- Abnormal nipple discharge (serous or blood-stained) not related to pregnancy or breastfeeding
- Skin dimpling, wrinkling, or nipple retraction (so-called “orange peel” skin, peau d’orange), which may indicate involvement of superficial lymphatic vessels
Self-examination tip: Every adult woman is encouraged to perform breast self-examination every 2–3 months. If you notice a lump or unusual mass, consult your physician promptly. While most lumps are benign, early evaluation is always advisable.
Imaging Studies
The most important diagnostic imaging tools include:
-
Mammography: Uses low-dose ionizing radiation to image breast tissue. It is also used for screening purposes. Starting from age 30–40, all women should undergo a baseline mammogram and, if results are normal, repeat it every 3–4 years as directed by their physician.
-
Breast Ultrasound: A non-invasive, repeatable imaging test that uses no ionizing radiation, making it completely safe. It is especially useful for evaluating suspected cystic or fluid-containing lesions and is often the first-line test in younger women with denser breast tissue.
-
Fine-Needle Aspiration Cytology (FNAC): Allows cytological analysis of cells aspirated from the lesion.
-
Core Needle Biopsy (CNB): Provides a definitive histological diagnosis, giving the most accurate and comprehensive assessment of the lesion’s nature.
Treatment
Watchful Waiting
In the majority of cases, fibroadenoma does not require any intervention. Monitoring through regular mammograms, ultrasounds, and specialist visits (clinical follow-up) is sufficient to ensure the lesion is not changing in a concerning way.
When Is Treatment Necessary?
Treatment may be required in the following situations:
- Complex fibroadenoma or one that is growing rapidly
- Suspicion of malignancy in one or more foci of the lesion
- Large or giant fibroadenoma causing discomfort or cosmetic concern
- Patient preference or significant anxiety
In these cases, histological analysis is typically performed first to guide the decision for surgical removal.
Surgical and Minimally Invasive Options
-
Cryoablation: A relatively recent technique that involves freezing and destroying the lesion. The main disadvantage is that histological analysis of the removed tissue is not possible, meaning it cannot be fully assessed after the procedure.
-
High-Intensity Focused Ultrasound (HIFU) Therapy: A minimally invasive option with a low complication profile. However, like cryoablation, it does not allow histological examination of the treated tissue.
-
Surgical Excision (Simple Excision or Quadrantectomy): The most widely performed and recommended approach for large or suspected fibroadenomas. It has the significant advantage of allowing complete histological analysis of the excised tissue, confirming the diagnosis and ruling out malignancy.
Pharmacological Treatment
From a pharmacological standpoint, oral contraceptive therapy may be beneficial in some cases. Studies have demonstrated that hormonal contraceptives can reduce the size of fibroadenomas in some women, likely by modulating estrogen and progesterone levels.
Important: Any treatment decision should be made in close consultation with a breast specialist (senologist) or surgeon, based on your individual clinical situation.
Sources and Bibliography
- Patel, S.G., Leger, R., et al. Surgical Pathology. Masson Editions.
- National Cancer Institute (NCI) – Breast Cancer Screening
- American College of Radiology (ACR) – Breast Imaging Reporting and Data System (BI-RADS)
- Dupont WD, et al. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol. 1987.
- Greenberg R, et al. The effect of oral contraceptives on the size of fibroadenomas: a randomized clinical trial. PubMed
- Sarnelli R, Squartini F. Fibrocystic condition and “at risk” lesions in asymptomatic breasts. Clin Exp Obstet Gynecol. 1991.
- World Health Organization (WHO) – Breast Cancer Overview
